Calciumfolinat Kabi

Calciumfolinat Kabi is a pharmaceutical product containing calcium folinate, used for various medical purposes. This intravenous solution is manufactured by Fresenius Kabi Deutschland Gmbh and is suitable for specific therapeutic applications.

Calciumfolinat Kabi is primarily used to counteract the effects of folic acid antagonists, such as methotrexate, in cases of overdose or toxicity. It is also utilized in the treatment of certain types of anemia and to enhance the effectiveness of specific chemotherapy regimens. Calcium folinate works by providing a form of folic acid that can bypass the blockage caused by these antagonists, thereby restoring normal folate metabolism.

When administered intravenously, Calciumfolinat Kabi can help to reduce the toxic effects of folic acid antagonists. It may also contribute to the improvement of symptoms related to folate deficiency, such as anemia. The specific effects can vary depending on the individual and the underlying condition being treated.

Calciumfolinat Kabi should be used with caution and under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Patients with a history of allergic reactions to folic acid or its derivatives should inform their healthcare provider before use.

Calciumfolinat Kabi may interact with certain medications, particularly those that affect folate metabolism. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other substances that affect liver function should be discussed with a healthcare professional.